Global Rare Disease Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 95 pages | ID: G3DE5FA0D7DEN
LP Information

Abstracts

According to this study, the global Rare Disease Diagnostics market size will reach US$ 41690 million by 2031.

Often rare diseases are chronic and life-threatening. Rare diseases can be single gene, multifactorial, chromosomal or non-genetic.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Rare Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Rare Disease Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Rare Disease Diagnostics sales for 2025 through 2031. With Rare Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rare Disease Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Rare Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Rare Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rare Disease Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rare Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rare Disease Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Hematology
• Oncology

Segmentation by Application:

• Hospital Laboratories
• Diagnostic Laboratories
• Genetic Testing Laboratories
• Cancer Research Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Retrophin
• 3billion
• 23andMe
• QIAGEN
• Illumina
• PerkinElmer
• Strand Life Sciences

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Rare Disease Diagnostics Market Size (2020-2031)
  2.1.2 Rare Disease Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Rare Disease Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Rare Disease Diagnostics Segment by Type
  2.2.1 Hematology
  2.2.2 Oncology
2.3 Rare Disease Diagnostics Market Size by Type
  2.3.1 Rare Disease Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Rare Disease Diagnostics Segment by Application
  2.4.1 Hospital Laboratories
  2.4.2 Diagnostic Laboratories
  2.4.3 Genetic Testing Laboratories
  2.4.4 Cancer Research Laboratories
  2.4.5 Others
2.5 Rare Disease Diagnostics Market Size by Application
  2.5.1 Rare Disease Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)

3 RARE DISEASE DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Rare Disease Diagnostics Market Size Market Share by Player
  3.1.1 Global Rare Disease Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Rare Disease Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Rare Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RARE DISEASE DIAGNOSTICS BY REGION

4.1 Rare Disease Diagnostics Market Size by Region (2020-2025)
4.2 Global Rare Disease Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Rare Disease Diagnostics Market Size Growth (2020-2025)
4.4 APAC Rare Disease Diagnostics Market Size Growth (2020-2025)
4.5 Europe Rare Disease Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Rare Disease Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Rare Disease Diagnostics Market Size by Country (2020-2025)
5.2 Americas Rare Disease Diagnostics Market Size by Type (2020-2025)
5.3 Americas Rare Disease Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Rare Disease Diagnostics Market Size by Region (2020-2025)
6.2 APAC Rare Disease Diagnostics Market Size by Type (2020-2025)
6.3 APAC Rare Disease Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Rare Disease Diagnostics Market Size by Country (2020-2025)
7.2 Europe Rare Disease Diagnostics Market Size by Type (2020-2025)
7.3 Europe Rare Disease Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Rare Disease Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Rare Disease Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Rare Disease Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RARE DISEASE DIAGNOSTICS MARKET FORECAST

10.1 Global Rare Disease Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Rare Disease Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Rare Disease Diagnostics Forecast
  10.1.3 APAC Rare Disease Diagnostics Forecast
  10.1.4 Europe Rare Disease Diagnostics Forecast
  10.1.5 Middle East & Africa Rare Disease Diagnostics Forecast
10.2 Americas Rare Disease Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Rare Disease Diagnostics Forecast
  10.2.2 Canada Market Rare Disease Diagnostics Forecast
  10.2.3 Mexico Market Rare Disease Diagnostics Forecast
  10.2.4 Brazil Market Rare Disease Diagnostics Forecast
10.3 APAC Rare Disease Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Rare Disease Diagnostics Market Forecast
  10.3.2 Japan Market Rare Disease Diagnostics Forecast
  10.3.3 Korea Market Rare Disease Diagnostics Forecast
  10.3.4 Southeast Asia Market Rare Disease Diagnostics Forecast
  10.3.5 India Market Rare Disease Diagnostics Forecast
  10.3.6 Australia Market Rare Disease Diagnostics Forecast
10.4 Europe Rare Disease Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Rare Disease Diagnostics Forecast
  10.4.2 France Market Rare Disease Diagnostics Forecast
  10.4.3 UK Market Rare Disease Diagnostics Forecast
  10.4.4 Italy Market Rare Disease Diagnostics Forecast
  10.4.5 Russia Market Rare Disease Diagnostics Forecast
10.5 Middle East & Africa Rare Disease Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Rare Disease Diagnostics Forecast
  10.5.2 South Africa Market Rare Disease Diagnostics Forecast
  10.5.3 Israel Market Rare Disease Diagnostics Forecast
  10.5.4 Turkey Market Rare Disease Diagnostics Forecast
10.6 Global Rare Disease Diagnostics Forecast by Type (2026-2031)
10.7 Global Rare Disease Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Rare Disease Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Retrophin
  11.1.1 Retrophin Company Information
  11.1.2 Retrophin Rare Disease Diagnostics Product Offered
  11.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Retrophin Main Business Overview
  11.1.5 Retrophin Latest Developments
11.2 3billion
  11.2.1 3billion Company Information
  11.2.2 3billion Rare Disease Diagnostics Product Offered
  11.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 3billion Main Business Overview
  11.2.5 3billion Latest Developments
11.3 23andMe
  11.3.1 23andMe Company Information
  11.3.2 23andMe Rare Disease Diagnostics Product Offered
  11.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 23andMe Main Business Overview
  11.3.5 23andMe Latest Developments
11.4 QIAGEN
  11.4.1 QIAGEN Company Information
  11.4.2 QIAGEN Rare Disease Diagnostics Product Offered
  11.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 QIAGEN Main Business Overview
  11.4.5 QIAGEN Latest Developments
11.5 Illumina
  11.5.1 Illumina Company Information
  11.5.2 Illumina Rare Disease Diagnostics Product Offered
  11.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Illumina Main Business Overview
  11.5.5 Illumina Latest Developments
11.6 PerkinElmer
  11.6.1 PerkinElmer Company Information
  11.6.2 PerkinElmer Rare Disease Diagnostics Product Offered
  11.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 PerkinElmer Main Business Overview
  11.6.5 PerkinElmer Latest Developments
11.7 Strand Life Sciences
  11.7.1 Strand Life Sciences Company Information
  11.7.2 Strand Life Sciences Rare Disease Diagnostics Product Offered
  11.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Strand Life Sciences Main Business Overview
  11.7.5 Strand Life Sciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Rare Disease Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Rare Disease Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Hematology
Table 4. Major Players of Oncology
Table 5. Rare Disease Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Rare Disease Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
Table 8. Rare Disease Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Rare Disease Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)
Table 11. Global Rare Disease Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Rare Disease Diagnostics Revenue Market Share by Player (2020-2025)
Table 13. Rare Disease Diagnostics Key Players Head office and Products Offered
Table 14. Rare Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rare Disease Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Rare Disease Diagnostics Market Size Market Share by Region (2020-2025)
Table 19. Global Rare Disease Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Rare Disease Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Rare Disease Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Rare Disease Diagnostics Market Size Market Share by Country (2020-2025)
Table 23. Americas Rare Disease Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
Table 25. Americas Rare Disease Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)
Table 27. APAC Rare Disease Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Rare Disease Diagnostics Market Size Market Share by Region (2020-2025)
Table 29. APAC Rare Disease Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Rare Disease Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Rare Disease Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Rare Disease Diagnostics Market Size Market Share by Country (2020-2025)
Table 33. Europe Rare Disease Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Rare Disease Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Rare Disease Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Rare Disease Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Rare Disease Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Rare Disease Diagnostics
Table 39. Key Market Challenges & Risks of Rare Disease Diagnostics
Table 40. Key Industry Trends of Rare Disease Diagnostics
Table 41. Global Rare Disease Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Rare Disease Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Rare Disease Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Rare Disease Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Retrophin Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 46. Retrophin Rare Disease Diagnostics Product Offered
Table 47. Retrophin Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Retrophin Main Business
Table 49. Retrophin Latest Developments
Table 50. 3billion Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 51. 3billion Rare Disease Diagnostics Product Offered
Table 52. 3billion Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. 3billion Main Business
Table 54. 3billion Latest Developments
Table 55. 23andMe Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 56. 23andMe Rare Disease Diagnostics Product Offered
Table 57. 23andMe Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. 23andMe Main Business
Table 59. 23andMe Latest Developments
Table 60. QIAGEN Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 61. QIAGEN Rare Disease Diagnostics Product Offered
Table 62. QIAGEN Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. QIAGEN Main Business
Table 64. QIAGEN Latest Developments
Table 65. Illumina Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 66. Illumina Rare Disease Diagnostics Product Offered
Table 67. Illumina Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Illumina Main Business
Table 69. Illumina Latest Developments
Table 70. PerkinElmer Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 71. PerkinElmer Rare Disease Diagnostics Product Offered
Table 72. PerkinElmer Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. PerkinElmer Main Business
Table 74. PerkinElmer Latest Developments
Table 75. Strand Life Sciences Details, Company Type, Rare Disease Diagnostics Area Served and Its Competitors
Table 76. Strand Life Sciences Rare Disease Diagnostics Product Offered
Table 77. Strand Life Sciences Rare Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Strand Life Sciences Main Business
Table 79. Strand Life Sciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Rare Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rare Disease Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Rare Disease Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Rare Disease Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Rare Disease Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Rare Disease Diagnostics Market Size Market Share by Type in 2024
Figure 10. Rare Disease Diagnostics in Hospital Laboratories
Figure 11. Global Rare Disease Diagnostics Market: Hospital Laboratories (2020-2025) & ($ millions)
Figure 12. Rare Disease Diagnostics in Diagnostic Laboratories
Figure 13. Global Rare Disease Diagnostics Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 14. Rare Disease Diagnostics in Genetic Testing Laboratories
Figure 15. Global Rare Disease Diagnostics Market: Genetic Testing Laboratories (2020-2025) & ($ millions)
Figure 16. Rare Disease Diagnostics in Cancer Research Laboratories
Figure 17. Global Rare Disease Diagnostics Market: Cancer Research Laboratories (2020-2025) & ($ millions)
Figure 18. Rare Disease Diagnostics in Others
Figure 19. Global Rare Disease Diagnostics Market: Others (2020-2025) & ($ millions)
Figure 20. Global Rare Disease Diagnostics Market Size Market Share by Application in 2024
Figure 21. Global Rare Disease Diagnostics Revenue Market Share by Player in 2024
Figure 22. Global Rare Disease Diagnostics Market Size Market Share by Region (2020-2025)
Figure 23. Americas Rare Disease Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. APAC Rare Disease Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Europe Rare Disease Diagnostics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Rare Disease Diagnostics Market Size 2020-2025 ($ millions)
Figure 27. Americas Rare Disease Diagnostics Value Market Share by Country in 2024
Figure 28. United States Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Rare Disease Diagnostics Market Size Market Share by Region in 2024
Figure 33. APAC Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
Figure 34. APAC Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)
Figure 35. China Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. India Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Rare Disease Diagnostics Market Size Market Share by Country in 2024
Figure 42. Europe Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
Figure 43. Europe Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)
Figure 44. Germany Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. France Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Rare Disease Diagnostics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Rare Disease Diagnostics Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Rare Disease Diagnostics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Rare Disease Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. APAC Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Europe Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. United States Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Canada Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Mexico Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Brazil Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. China Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Japan Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Korea Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. India Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Australia Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Germany Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. France Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. UK Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Italy Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Russia Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Egypt Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. South Africa Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Israel Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 79. Turkey Rare Disease Diagnostics Market Size 2026-2031 ($ millions)
Figure 80. Global Rare Disease Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Rare Disease Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Rare Disease Diagnostics Market Size 2026-2031 ($ millions)